Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
NCT Number: NCT04409236
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Phase 3
Seattle, Washington, 98109, United States
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.
ARM II: Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.
After randomization, patients are followed up at 3, 6, and 12 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use Quit2Heal app
Other names: Quit2Heal App, Quit2Heal Smartphone App, Quit2Heal Smartphone Application
Use QuitGuide app
Other names: QuitGuide App, QuitGuide Smartphone App, QuitGuide Smartphone Application
Ancillary studies
Time frame: At 12 months after randomization
No smoking at all in the past 30 or more days.
Time frame: At 3 months after randomization
No smoking at all in the past 30 or more days.
Time frame: At 6 months after randomization
No smoking at all in the past 30 or more days.
Fred Hutchinson Cancer Center
Other
Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking (Quit2Heal)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05868486
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Duarte, California, United States
View Trial DetailsNCT04494945
Adenocarcinoma, Adnexal Diseases
Portland, Oregon, United States
View Trial DetailsNCT06015932
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Rochester, Minnesota, United States
View Trial DetailsNCT06314672
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Columbus, Ohio, United States
View Trial Details